Literature DB >> 33585934

Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader.

Vasanthi Avadhanula1, Erin G Nicholson1,2, Laura Ferlic-Stark1, Felipe-Andres Piedra1, Brittani N Blunck1, Sonia Fragoso1, Nanette L Bond1, Patricia L Santarcangelo1, Xunyan Ye1, Trevor J McBride1, Letisha O Aideyan1, Kirtida D Patel1, Lauren Maurer1, Laura S Angelo1, Pedro A Piedra1,2.   

Abstract

BACKGROUND: During the coronavirus disease 2019 pandemic, a minority of index cases are associated with a majority of secondary cases suggesting that superspreaders could drive the pandemic. We identified a phenotype in individuals with extremely high viral load who could act as superspreaders.
METHODS: Data were analyzed from individuals tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 18 March through 15 August 2020. Outcomes were compared using contingency table and quantile regression to test the equality of medians between the pandemic waves and by viral load groups.
RESULTS: Of the 11 564 samples tested, 1319 (11.4%) were positive for SARS-CoV-2. An increase in weekly median viral load occurred in the second wave of the SARS-CoV2 pandemic. This population was more likely to be women, outpatients, and symptomatic and to have an extremely high or high viral load. In patients with multiple reverse-transcription polymerase chain reaction-positive test results, the durations of viral shedding were comparable between individuals with asymptomatic/mild and mild/moderate illness severity.
CONCLUSIONS: We detected a small group of individuals with extremely high SARS-CoV-2 viral loads and mild illness. We believe that these individuals' characteristics could be consistent with the superspreader phenomenon and that greater awareness of the social dynamics of these individuals is needed to understand the spread of SARS-CoV-2.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; cycle threshold; extremely high viral load; superspreader; viral load kinetics

Year:  2021        PMID: 33585934      PMCID: PMC7928726          DOI: 10.1093/infdis/jiab097

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City.

Authors:  Carlos Eduardo Covantes-Rosales; Victor Wagner Barajas-Carrillo; Daniel Alberto Girón-Pérez; Gladys Alejandra Toledo-Ibarra; Karina Janice Guadalupe Díaz-Reséndiz; Migdalia Sarahy Navidad-Murrieta; Guadalupe Herminia Ventura-Ramón; Mirtha Elena Pulido-Muñoz; Ulises Mercado-Salgado; Ansonny Jhovanny Ojeda-Durán; Aimée Argüero-Fonseca; Manuel Iván Girón-Pérez
Journal:  Int J Environ Res Public Health       Date:  2022-05-08       Impact factor: 4.614

2.  SARS-CoV-2 re-infection versus prolonged shedding: A case series.

Authors:  Erin G Nicholson; Vasanthi Avadhanula; Sonia Fragoso; Rachel Stroh; Xunyan Ye; Nanette Bond; Patricia Santarcangelo; John Stroh; Pedro A Piedra
Journal:  Influenza Other Respir Viruses       Date:  2021-06-04       Impact factor: 5.606

3.  Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.

Authors:  Matthias Pilecky; Stephan Harm; Christoph Bauer; Jennifer Zottl; Robert Emprechtinger; Tanja Eichhorn; Claudia Schildböck; Michael Ecker; Martin Willheim; Viktoria Weber; Jens Hartmann
Journal:  J Infect       Date:  2022-01-14       Impact factor: 38.637

4.  A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.

Authors:  Juliette Leon; Daniel A Michelson; Judith Olejnik; Kaitavjeet Chowdhary; Hyung Suk Oh; Adam J Hume; Silvia Galván-Peña; Yangyang Zhu; Felicia Chen; Brinda Vijaykumar; Liang Yang; Elena Crestani; Lael M Yonker; David M Knipe; Elke Mühlberger; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 11.205

5.  Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing.

Authors:  Hsing-Yi Chung; Ming-Jr Jian; Chih-Kai Chang; Jung-Chung Lin; Kuo-Ming Yeh; Ya-Sung Yang; Chien-Wen Chen; Shan-Shan Hsieh; Sheng-Hui Tang; Cherng-Lih Perng; Feng-Yee Chang; Kuo-Sheng Hung; En-Sung Chen; Mei-Hsiu Yang; Hung-Sheng Shang
Journal:  Aging (Albany NY)       Date:  2021-12-12       Impact factor: 5.682

6.  Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults.

Authors:  Lacy M Simons; Ramon Lorenzo-Redondo; Meg Gibson; Sarah L Kinch; Jacob P Vandervaart; Nina L Reiser; Mesut Eren; Elizabeth Lux; Elizabeth M McNally; Anat R Tambur; Douglas E Vaughan; Kelly E R Bachta; Alexis R Demonbreun; Karla J F Satchell; Chad J Achenbach; Egon A Ozer; Michael G Ison; Judd F Hultquist
Journal:  Open Forum Infect Dis       Date:  2022-02-14       Impact factor: 3.835

7.  Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 - A multicenter retrospective observation study.

Authors:  James P d'Etienne; Naomi Alanis; Eric Chou; John S Garrett; Jessica J Kirby; David P Bryant; Sajid Shaikh; Chet D Schrader; Hao Wang
Journal:  Am J Emerg Med       Date:  2022-03-10       Impact factor: 4.093

8.  The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics.

Authors:  Anubama Rajan; Ashley Morgan Weaver; Gina Marie Aloisio; Joseph Jelinski; Hannah L Johnson; Susan F Venable; Trevor McBride; Letisha Aideyan; Felipe-Andrés Piedra; Xunyan Ye; Ernestina Melicoff-Portillo; Malli Rama Kanthi Yerramilli; Xi-Lei Zeng; Michael A Mancini; Fabio Stossi; Anthony W Maresso; Shalaka A Kotkar; Mary K Estes; Sarah Blutt; Vasanthi Avadhanula; Pedro A Piedra
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

9.  Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study.

Authors:  Terry Lee; Matthew P Cheng; Donald C Vinh; Todd C Lee; Karen C Tran; Brent W Winston; David Sweet; John H Boyd; Keith R Walley; Greg Haljan; Allison McGeer; François Lamontagne; Robert Fowler; David Maslove; Joel Singer; David M Patrick; John C Marshall; Kevin D Burns; Srinivas Murthy; Puneet K Mann; Geraldine Hernandez; Kathryn Donohoe; Genevieve Rocheleau; James A Russell
Journal:  CMAJ Open       Date:  2022-04-19

10.  Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.

Authors:  André Voigt; Stig Omholt; Eivind Almaas
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.